首頁 > 市場調查報告書 > 醫療設備

體外診斷

市場調查報告書

商品編碼

1418378

胎兒遊離 DNA 檢測市場報告：2030 年趨勢、預測與競爭分析

Cell Free Fetal DNA Testing Market Report: Trends, Forecast and Competitive Analysis to 2030

出版日期: 2024年01月29日 | 出版商:

Lucintel | 英文 150 - page report | 商品交期: 3個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

胎兒遊離 DNA 檢測的趨勢與預測

預計 2024 年至 2030 年，全球胎兒遊離 DNA 檢測市場將以 12.3% 的複合年成長率成長。該市場的主要促進因素是人們對遺傳疾病的認知不斷提高，以及產科對安全、低風險的產前診斷技術的日益偏好。胎兒遊離DNA檢測的全球市場前景廣闊，在醫院和臨床中心的應用機會龐大。

胎兒遊離 DNA 檢測市場洞察

Lucintel 預測，染色體畸變檢測預計將在預測期內呈現最高成長，因為它被廣泛用於檢測各種染色體異常。

由於其發達的醫療保健系統以及與遊離 DNA 檢測相關的各種疾病的發生頻率不斷增加，預計北美在預測期內將出現最高的成長。

常問問題

Q1.市場成長預測如何？

A1. 預計 2024 年至 2030 年，全球胎兒遊離 DNA 檢測市場將以 12.3% 的複合年成長率成長。

Q2.影響市場成長的主要促進因素有哪些？

A2. 該市場的主要驅動力是人們對遺傳疾病的認知不斷提高，以及產科對安全、低風險的產前診斷技術的日益偏好。

Q3.市場的主要細分市場有哪些？

A3. 胎兒遊離DNA檢測市場的前景看好，醫院和臨床中心市場也充滿機會。

Q4.市場上主要企業有哪些？

A4.進行胎兒遊離DNA檢測的主要企業如下。

The Fetal Medicine Centre
Apollo Path labs
Ariosa Diagnostics
Sequenom Laboratories
Laboratory Corporation of America Holdings
Personal Genome Diagnostics
Premaitha Health
Berry Genomics
Roche Holdings
Trovagene

Q5.未來最大的細分市場是什麼？

A5.Lucintel預測異常染色體數目檢測將在預測期內呈現最高成長，因為它被廣泛用於檢測各種染色體異常。

Q6. 未來五年預計哪個地區將成為最大的市場？

A6. 由於其發達的醫療保健系統以及該地區人口中與遊離DNA檢測相關的各種疾病的發生頻率不斷增加，北美將在預測期內出現最高的成長。

Q7. 可以客製化報告嗎？

A7. 是的，Lucintel 提供 10% 的客製化服務，無需額外費用。

宏觀經濟趨勢（2018-2023）與預測（2024-2030）
胎兒遊離DNA檢測的全球市場趨勢（2018-2023）與預測（2024-2030）
按類型分類的全球胎兒遊離 DNA 檢測市場
- 染色體數目異常檢測
- 性別測試
- 父系遺傳疾病檢測
- 親子鑑定
- 其他
胎兒遊離 DNA 檢測的全球市場：依應用分類
- 醫院
- 診所中心
- 其他

第4章 2018-2030年區域市場趨勢及預測分析

按地區分類的全球胎兒遊離 DNA 檢測市場
北美胎兒遊離DNA檢測市場
歐洲胎兒遊離DNA檢測市場
亞太胎兒遊離DNA檢測市場
其他地區胎兒遊離DNA檢測市場

第5章競爭分析

產品系列分析
營運整合
波特五力分析

第6章成長機會與策略分析

成長機會分析
- 全球胎兒遊離 DNA 檢測市場成長機會（按類型）
- 全球胎兒遊離 DNA 檢測市場成長機會（按應用）
- 全球胎兒遊離 DNA 檢測市場成長機會（按地區）
全球胎兒遊離DNA檢測市場新趨勢
戰略分析
- 新產品開發
- 擴大胎兒遊離 DNA 檢測的全球市場容量
- 全球胎兒遊離DNA檢測市場的合併、收購與合資
- 認證和許可

第7章主要企業概況

The Fetal Medicine Centre
Apollo Path labs
Ariosa Diagnostics
Sequenom Laboratories
Laboratory Corporation of America Holdings
Personal Genome Diagnostics
Premaitha Health
Berry Genomics
Roche Holdings
Trovagene

簡介目錄

Cell Free Fetal DNA Testing Trends and Forecast

The future of the global cell free fetal DNA testing market looks promising with opportunities in the hospital and clinic center applications. The global cell free fetal DNA testing market is expected to grow with a CAGR of 12.3% from 2024 to 2030. The major drivers for this market are raising consciousness regarding genetic disorders and growing preference for secure and minimally risky prenatal diagnostic techniques in obstetrics.

A more than 150-page report is developed to help in your business decisions.

Cell Free Fetal DNA Testing by Segment

The study includes a forecast for the global cell free fetal DNA testing by type, application, and region.

Cell Free Fetal DNA Testing Market by Type [Shipment Analysis by Value from 2018 to 2030]:

Abnormal Chromosome Number Detection
Gender Testing
Paternally Inherited Disorder Detection
Paternity Testing
Others

Cell Free Fetal DNA Testing Market by Application [Shipment Analysis by Value from 2018 to 2030]:

Hospital
Clinic Center
Others

Cell Free Fetal DNA Testing Market by Region [Shipment Analysis by Value from 2018 to 2030]:

North America
Europe
Asia Pacific
The Rest of the World

List of Cell Free Fetal DNA Testing Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies cell free fetal DNA testing companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the cell free fetal DNA testing companies profiled in this report include-

The Fetal Medicine Centre
Apollo Path labs
Ariosa Diagnostics
Sequenom Laboratories
Laboratory Corporation of America Holdings
Personal Genome Diagnostics
Premaitha Health
Berry Genomics
Roche Holdings
Trovagene

Cell Free Fetal DNA Testing Market Insights

Lucintel forecasts that abnormal chromosome number detection is expected to witness highest growth over the forecast period due to its widespread use in detecting variety of chromosomal disorders.

North America is expected to witness highest growth over the forecast period due to existence of developed healthcare system and increasing frequency of various diseases linked to cell-free DNA testing among population of the region.

Features of the Global Cell Free Fetal DNA Testing Market

Market Size Estimates: Cell free fetal DNA testing market size estimation in terms of value ($B).

Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.

Segmentation Analysis: Cell free fetal DNA testing market size by type, application, and region in terms of value ($B).

Regional Analysis: Cell free fetal DNA testing market breakdown by North America, Europe, Asia Pacific, and Rest of the World.

Growth Opportunities: Analysis of growth opportunities in different types, applications, and regions for the cell free fetal DNA testing market.

Strategic Analysis: This includes M&A, new product development, and competitive landscape of the cell free fetal DNA testing market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

FAQ

Q1. What is the growth forecast for cell free fetal DNA testing market?

Answer: The global cell free fetal DNA testing market is expected to grow with a CAGR of 12.3% from 2024 to 2030.

Q2. What are the major drivers influencing the growth of the cell free fetal DNA testing market?

Answer: The major drivers for this market are raising consciousness regarding genetic disorders and growing preference for secure and minimally risky prenatal diagnostic techniques in obstetrics.

Q3. What are the major segments for cell free fetal DNA testing market?

Answer: The future of the cell free fetal DNA testing market looks promising with opportunities in the hospital and clinic center markets.

Q4. Who are the key cell free fetal DNA testing market companies?

Answer: Some of the key cell free fetal DNA testing companies are as follows.

The Fetal Medicine Centre
Apollo Path labs
Ariosa Diagnostics
Sequenom Laboratories
Laboratory Corporation of America Holdings
Personal Genome Diagnostics
Premaitha Health
Berry Genomics
Roche Holdings
Trovagene

Q5. Which cell free fetal DNA testing market segment will be the largest in future?

Answer: Lucintel forecasts that abnormal chromosome number detection is expected to witness highest growth over the forecast period due to its widespread use in detecting variety of chromosomal disorders.

Q6. In cell free fetal DNA testing market, which region is expected to be the largest in next 5 years?

Answer: North America is expected to witness highest growth over the forecast period due to existence of developed healthcare system and increasing frequency of various diseases linked to cell-free DNA testing among population of the region.

Q7. Do we receive customization in this report?

Answer: Yes, Lucintel provides 10% customization without any additional cost.

This report answers following 11 key questions:

Q.1. What are some of the most promising, high-growth opportunities for the cell free fetal DNA testing market by type (abnormal chromosome number detection, gender testing, paternally inherited disorder detection, paternity testing, and others), application (hospital, clinic center, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
Q.2. Which segments will grow at a faster pace and why?
Q.3. Which region will grow at a faster pace and why?
Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
Q.5. What are the business risks and competitive threats in this market?
Q.6. What are the emerging trends in this market and the reasons behind them?
Q.7. What are some of the changing demands of customers in the market?
Q.8. What are the new developments in the market? Which companies are leading these developments?
Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?

1. Executive Summary

2. Global Cell Free Fetal DNA Testing Market : Market Dynamics

2.1: Introduction, Background, and Classifications
2.2: Supply Chain
2.3: Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2018 to 2030

3.1. Macroeconomic Trends (2018-2023) and Forecast (2024-2030)
3.2. Global Cell Free Fetal DNA Testing Market Trends (2018-2023) and Forecast (2024-2030)
3.3: Global Cell Free Fetal DNA Testing Market by Type
- 3.3.1: Abnormal Chromosome Number Detection
- 3.3.2: Gender Testing
- 3.3.3: Paternally Inherited Disorder Detection
- 3.3.4: Paternity Testing
- 3.3.5: Others
3.4: Global Cell Free Fetal DNA Testing Market by Application
- 3.4.1: Hospital
- 3.4.2: Clinic Center
- 3.4.3: Others

4. Market Trends and Forecast Analysis by Region from 2018 to 2030

4.1: Global Cell Free Fetal DNA Testing Market by Region
4.2: North American Cell Free Fetal DNA Testing Market
- 4.2.2: North American Cell Free Fetal DNA Testing Market by Application: Hospital, Clinic Center, and Others
4.3: European Cell Free Fetal DNA Testing Market
- 4.3.1: European Cell Free Fetal DNA Testing Market by Type: Abnormal Chromosome Number Detection, Gender Testing, Paternally Inherited Disorder Detection, Paternity Testing, and Others
- 4.3.2: European Cell Free Fetal DNA Testing Market by Application: Hospital, Clinic Center, and Others
4.4: APAC Cell Free Fetal DNA Testing Market
- 4.4.1: APAC Cell Free Fetal DNA Testing Market by Type: Abnormal Chromosome Number Detection, Gender Testing, Paternally Inherited Disorder Detection, Paternity Testing, and Others
- 4.4.2: APAC Cell Free Fetal DNA Testing Market by Application: Hospital, Clinic Center, and Others
4.5: ROW Cell Free Fetal DNA Testing Market
- 4.5.1: ROW Cell Free Fetal DNA Testing Market by Type: Abnormal Chromosome Number Detection, Gender Testing, Paternally Inherited Disorder Detection, Paternity Testing, and Others
- 4.5.2: ROW Cell Free Fetal DNA Testing Market by Application: Hospital, Clinic Center, and Others

5. Competitor Analysis

5.1: Product Portfolio Analysis
5.2: Operational Integration
5.3: Porter's Five Forces Analysis

6. Growth Opportunities and Strategic Analysis

6.1: Growth Opportunity Analysis
- 6.1.1: Growth Opportunities for the Global Cell Free Fetal DNA Testing Market by Type
- 6.1.2: Growth Opportunities for the Global Cell Free Fetal DNA Testing Market by Application
- 6.1.3: Growth Opportunities for the Global Cell Free Fetal DNA Testing Market by Region
6.2: Emerging Trends in the Global Cell Free Fetal DNA Testing Market
6.3: Strategic Analysis
- 6.3.1: New Product Development
- 6.3.2: Capacity Expansion of the Global Cell Free Fetal DNA Testing Market
- 6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Cell Free Fetal DNA Testing Market
- 6.3.4: Certification and Licensing